CAS: 1622291-66-0
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one REF: 3D-XPC29166CAS: 1622291-66-0 | Min. 95% | A consultar | Mié 18 Dic 24 | |
PF-06462894 REF: TM-T28372CAS: 1622291-66-0 | 98% | 1.742,00 €~4.844,00 € | Mié 05 Feb 25 |
(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one
CAS:1622291-66-0
(6R)-6-(2,2-Dimethylpropyl)-2-(pyridin-2-ylmethoxy)-7,9-dihydro-6H-pyrimido[2,1-c][1,4]oxazin-4-one is a drug that has been found to be reactive in nonhuman primates. This …
Fórmula:
C18H23N3O3
Pureza:
Min. 95%
Peso molecular:
329.4 g/mol
Ref: 3D-XPC29166
10mg | A consultar | ||
25mg | A consultar | ||
50mg | A consultar |
Entrega estimada en Estados Unidos, el Miércoles 18 de Diciembre de 2024
PF-06462894
CAS:1622291-66-0
PF-06462894: morpholinopyrimidone, mGlu5 antagonist (Ki=6nM), no immune activation in mouse model.
Fórmula:
C18H23N3O3
Pureza:
98%
Forma y color:
Solid
Peso molecular:
329.39
Ref: TM-T28372
25mg | 2.662,00 € | ||
50mg | 3.522,00 € | ||
100mg | 4.844,00 € |
Entrega estimada en Estados Unidos, el Miércoles 5 de Febrero de 2025